Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Net Income (2016 - 2025)

Historic Net Income for Niagen Bioscience (NAGE) over the last 16 years, with Q3 2025 value amounting to $4.6 million.

  • Niagen Bioscience's Net Income rose 14377.0% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year increase of 127569.02%. This contributed to the annual value of $8.5 million for FY2024, which is 27314.7% up from last year.
  • As of Q3 2025, Niagen Bioscience's Net Income stood at $4.6 million, which was up 14377.0% from $3.6 million recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Net Income registered a high of $7.2 million during Q4 2024, and its lowest value of -$8.9 million during Q3 2021.
  • For the 5-year period, Niagen Bioscience's Net Income averaged around -$1.5 million, with its median value being -$1.4 million (2022).
  • Its Net Income has fluctuated over the past 5 years, first crashed by 11010.68% in 2021, then surged by 2416000.0% in 2025.
  • Quarter analysis of 5 years shows Niagen Bioscience's Net Income stood at -$5.3 million in 2021, then soared by 72.88% to -$1.4 million in 2022, then soared by 107.89% to $114000.0 in 2023, then soared by 6197.37% to $7.2 million in 2024, then tumbled by 36.23% to $4.6 million in 2025.
  • Its Net Income was $4.6 million in Q3 2025, compared to $3.6 million in Q2 2025 and $5.1 million in Q1 2025.